Academic Journal
Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015
| العنوان: | Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015 |
|---|---|
| المؤلفون: | Glocker, Catherine, Grohmann, R., Engel, R., Seifert, J., Bleich, S., Stübner, S., Toto, S., Schüle, C. |
| المصدر: | http://lobid.org/resources/99370678531806441#!, 271(8):1425-1435. |
| سنة النشر: | 2021 |
| المجموعة: | Publisso (ZB MED-Publikationsportal Lebenswissenschaften) |
| مصطلحات موضوعية: | Adolescent [MeSH], Female [MeSH], Pharmacovigilance [MeSH], Antipsychotic Agents/adverse effects [MeSH], Adult [MeSH], Galactorrhea/epidemiology [MeSH], Humans [MeSH], Galactorrhea/chemically induced [MeSH], Psychiatric inpatients, Adverse drug reactions, Original Paper, Young Adult [MeSH], AMSP program, Antipsychotic drugs, Galactorrhea |
| الوصف: | Galactorrhea is a well-known adverse drug reaction (ADR) of numerous antipsychotic drugs (APD) and is often distressing for those affected. Methodological problems in the existing literature make it difficult to determine the prevalence of symptomatic hyperprolactinemia in persons treated with APDs. Consequently, a large sample of patients exposed to APDs is needed for more extensive evaluation. Data on APD utilization and reports of galactorrhea caused by APDs were analyzed using data from an observational pharmacovigilance program in German-speaking countries-Arzneimittelsicherheit in der Psychiatrie (AMSP)-from 1993 to 2015. 320,383 patients (175,884 female inpatients) under surveillance were treated with APDs for schizophrenia and other indications. A total of 170 events of galactorrhea caused by APDs were identified (0.97 cases in 1000 female inpatient admissions). Most cases occurred during the reproductive age with the highest incidence among patients between 16 and 30 years (3.81 cases in 1000 inpatients). The APDs that were most frequently imputed alone for inducing galactorrhea were risperidone (52 cases and 0.19% of all exposed inpatients), amisulpride (30 resp. 0.48%), and olanzapine (13 resp. 0.05%). In three cases, quetiapine had a prominent role as a probable cause for galactorrhea. High dosages of the imputed APDs correlated with higher rates of galactorrhea. Galactorrhea is a severe and underestimated condition in psychopharmacology. While some APDs are more likely to cause galactorrhea, we identified a few unusual cases. This highlights the importance of alertness in clinical practice and of taking a patient's individual situation into consideration. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| Relation: | https://repository.publisso.de/resource/frl:6450352; https://doi.org/10.1007/s00406-021-01241-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563638/ |
| DOI: | 10.1007/s00406-021-01241-3 |
| الاتاحة: | https://repository.publisso.de/resource/frl:6450352 https://doi.org/10.1007/s00406-021-01241-3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563638/ |
| Rights: | https://creativecommons.org/licenses/by/4.0/ |
| رقم الانضمام: | edsbas.E21E41A1 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1007/s00406-021-01241-3 |
|---|